🔴 Royalty Pharma is trading 4.3% down in pre-market with U.S. futures pointing lower

Royalty Pharma is trading 4.31% lower at $61.00, with no new company-specific announcement identified for October 23.

• Supplied price context lists the October 22 close at $63.75.
• The company’s latest listed news is its October 16 dividend announcement.
• Reuters reported rising oil prices and Middle East supply concerns as U.S. futures pointed lower; this broader caution does not establish a direct cause for the stock’s move.